Forte Biosciences experiences a significant increase in global media mentions, with 30 reports within a short time frame, signaling heightened interest.
Molina Healthcare has experienced a surge in international coverage, with mentions increasing over sevenfold according to GDELT data. The move signals a strategic shift.
AstraZeneca has experienced a significant increase in global media mentions, with 25 times the usual coverage, signaling heightened public and media interest.
The FDA is examining reports of adverse effects associated with Tylenol, prompting health officials to review safety data. No recalls have been issued yet.
The FDA has approved a new extended-release formulation of cetirizine, aiming to improve allergy symptom management. Details on availability are forthcoming.
New research confirms that handwriting improves brain activity and cognitive skills, highlighting its benefits over typing for mental health and learning.